# KALETRA
> **NDA021226** · New Drug Application · Sponsor: ABBVIE · Approved 2000-09-15
## Drug
- **FDA Application Number:** NDA021226
- **Application type:** New Drug Application
- **Brand name:** KALETRA
- **Generic name:** Lopinavir
- **Active ingredients:** LOPINAVIR; RITONAVIR
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** ABBVIE
- **First approval:** 2000-09-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021226)
---
*AI Analytics · CC0 1.0*